Granahan Investment Management, LLC Blueprint Medicines Corp Transaction History

Granahan Investment Management, LLC

$2.12 Billion
Q4 2024

A detailed history of Granahan Investment Management, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Granahan Investment Management, LLC holds 141,890 shares of BPMC stock, worth $13.5 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

141,890

Previous 131,146 8.19%

Holding current value

$13.5 Million

Previous $12.1 Million 2.06%

% of portfolio

0.58%

Previous 0.51%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$82.48 - $101.39 $886,165 - $1.09 Million	10,744 Added 8.19%	141,890 $12.4 Million
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $722,082 - $1.03 Million	-8,586 Reduced 6.14%	131,146 $12.1 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $3.37 Million - $4.31 Million	-39,585 Reduced 22.08%	139,732 $15.1 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $864,137 - $1.18 Million	11,810 Added 7.05%	179,317 $17 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $2.71 Million - $5.73 Million	-61,740 Reduced 26.93%	167,507 $15.5 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $2.1 Million - $2.95 Million	44,744 Added 24.25%	229,247 $11.5 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $2.01 Million - $3.17 Million	-47,716 Reduced 20.55%	184,503 $11.7 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $281,167 - $370,250	7,405 Added 3.29%	232,219 $10.4 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $3.31 Million - $5.36 Million	80,637 Added 55.93%	224,814 $9.85 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $2.02 Million - $3.15 Million	40,531 Added 39.11%	144,177 $9.5 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $2.4 Million - $3.72 Million	-53,000 Reduced 33.83%	103,646 $5.24 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $5.73 Million - $11.7 Million	105,921 Added 208.81%	156,646 $10 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $195,286 - $240,331	-2,072 Reduced 3.92%	50,725 $5.43 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $767,771 - $1.04 Million	-9,481 Reduced 15.22%	52,797 $5.43 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $279,051 - $340,471	3,371 Added 5.72%	62,278 $5.48 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $3.53 Million - $4.21 Million	-38,875 Reduced 39.76%	58,907 $5.73 Million
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $2.83 Million - $3.83 Million	-30,777 Reduced 23.94%	97,782 $11 Million
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $1.19 Million - $1.65 Million	17,833 Added 16.11%	128,559 $11.9 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $6.32 Million - $8.78 Million	110,726 New	110,726 $8.64 Million

Others Institutions Holding BPMC

# of Institutions

379

Shares Held

61.6M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.69B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account

Granahan Investment Management, LLC Blueprint Medicines Corp Transaction History